Biomarin wins FDA nod for phenylketonuria drug

The FDA granted approval to Biomarin Pharmaceutical's Palynziq, or pegvaliase-pqpz, for use in reducing blood phenylalanine c -More- …
Read the full story: BIO SmartBrief